Repligen Corporation
Status: Publicly traded
Direct answer
Repligen Corporation is publicly traded on NASDAQ under the ticker RGEN.
Repligen Corporation specializes in the creation and distribution of advanced bioprocessing technologies and integrated systems. These solutions are vital for various stages of biological drug production, serving clients across North America, Europe, the Asia Pacific region, and other international markets. The company's diverse product portfolio includes crucial components for biomanufacturing. This encompasses...
Can you invest in Repligen Corporation?
Yes. Repligen Corporation trades publicly on NASDAQ as RGEN.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Repligen Corporation
Detailed equity research is provided by MarketSnap.